REGNON

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion.

Name REGNON

Rank No.3662

Market Cap $0.00

Fully Diluted Market Cap $0.00

Market Share %

Trading Vol/Market Cap (24H) 76,547,162.76%

Circulation Supply 0.93696396

Max Supply 0

Total Supply 0.93696396

Circulation Rate %

Issue Date --

The price at which the asset was first issued --

All-Time High 778.9210127183559, 2026-04-02

Lowest Price 608.0821849052599, 2026-05-18

Public Blockchain REGNON

Introduction Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion.

Sector

Social Media

• Twitter

• Official Website
• Block Explorer

Fund Flow Analysis

etfindex:mc_etfindex_source Disclaimer: Data provided by cmc and should not be considered as investment advice.